Berberine exerts anti-inflammatory effects by inhibiting the TLR4/NF-κB pathway, in addition to its anti-platelet aggregation and anti-atherosclerosis properties, making it a promising drug for the treatment of stroke [78]. The gene discussed is NFKB1; the disease is Stroke.